Friday, December 13, 2024

Tag: Nervous System

Researchers identify promising therapeutic target for central nervous system injuries

Scars can serve as double-edged swords in spinal cord injuries—saving a victim's life, but sealing his or her fate as a paraplegic or quadriplegic....

Immune response to spinal cord injury may worsen damage

COLUMBUS, Ohio – After spinal cord injury, certain immune cells collect in the spinal fluid and release high levels of antibodies. What, if anything,...

Electrical nerve stimulation may relieve neuropathic pain after spinal cord injury

A new study has revealed that electrical nerve stimulation can effectively reduce neuropathic pain following a spinal cord injury. Neuropathic pain is often difficult to...

Finding the right connection after spinal cord injury

In a major step in spinal cord injury research, scientists at the University of California, San Diego School of Medicine have demonstrated that regenerating...

Infiltrating blood-derived macrophages are vital cells in recovery from spinal cord injury in mice

Although macrophages (MΦ) are known as essential players in wound healing, their contribution to recovery from spinal cord injury (SCI) is a subject of...

Spinal Cord Injury Research Focus of Bryon Riesch Paralysis Foundation Grant

Support from the Bryon Riesch Paralysis Foundation will allow a Medical College of Wisconsin faculty member to research whether neurally modified cells derived from...

The dormant potential of damaged nerve cells

Damaged nerve cells in a finger will regrow, but those in the spinal cord do not. Why the difference? Scientists at the Max Planck...

‘Oh my God, they are going to kill someone’

Man struggles to put life together after crash What they remember most are the sounds. For Evan Cronhardt, it was the sound of his life changing...

Doctors at AIIMS operate on spinal injury, boy walks

New Delhi: A 10-year-old boy from a village in Uttar Pradesh has gained a new lease of life after the doctors at AIIMS operated...

XenoPort Reports Positive Results from Phase 2 Trial of Arbaclofen Placarbil in Spinal Cord...

XenoPort Reports Positive Results from a Phase 2 Trial of Arbaclofen Placarbil in Spinal Cord Injury Patients with Spasticity SANTA CLARA, Calif.- XenoPort, Inc. announced...